Cargando…

Editorial: The advances in proteomics and targeted therapy of malignant brain tumours

Detalles Bibliográficos
Autores principales:	Chen, Anjing, An, Zhenyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168536/ https://www.ncbi.nlm.nih.gov/pubmed/37182126 http://dx.doi.org/10.3389/fonc.2023.1195847

Ejemplares similares

Editorial: Advances of Targeted Therapy in Gynecologic Malignancies
por: Qiu, Haifeng, et al.
Publicado: (2022)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Ferroptosis in malignant brain tumors
por: Yakubov, Eduard, et al.
Publicado: (2023)

Editorial: Advances in the Diagnosis and Treatment of Skull Base Tumours
por: Cleere, Eoin F., et al.
Publicado: (2022)

Editorial: Advances in molecular targeted therapies of urologic cancers
por: Nitzsche, Bianca, et al.
Publicado: (2022)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

Editorial: Novel targeted drugs for indolent lymphoid malignancies
por: Robak, Tadeusz, et al.
Publicado: (2023)

Advances in CAR T cell immunotherapy for paediatric brain tumours
por: Rao, Padmashree, et al.
Publicado: (2022)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Editorial: Treatment for advanced breast cancer with brain metastases
por: Yan, Min, et al.
Publicado: (2023)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies
por: Sahu, Ram Kumar, et al.
Publicado: (2023)

Editorial: Proteomics and Its Applications in Cancer
por: Thakur, Suman S., et al.
Publicado: (2021)

Advanced Targeted, Cell and Gene-Therapy Approaches for Pediatric Hematological Malignancies: Results and Future Perspectives
por: Magnani, Chiara F., et al.
Publicado: (2013)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

The immunotherapy advancement targeting malignant blastomas in early childhood
por: Zang, Bolun, et al.
Publicado: (2023)

Targeting MYCN in Molecularly Defined Malignant Brain Tumors
por: Borgenvik, Anna, et al.
Publicado: (2021)

Editorial: Current Perspectives, Challenges and Advances in Cell Based Therapies
por: Thakar, Monica S., et al.
Publicado: (2020)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

Editorial: The role of imaging in gynecological malignancies
por: Han, Kathy, et al.
Publicado: (2023)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: Targeted Therapies for Glioblastoma: A Critical Appraisal
por: Gupta, Shiv K., et al.
Publicado: (2019)

Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis
por: Bhutani, Divaya, et al.
Publicado: (2023)

Editorial: Recent advances of drug resistance research in colorectal cancer therapy
por: Ye, Chenyang, et al.
Publicado: (2022)

Editorial: The notch signaling pathway in lymphoid malignancies
por: Fais, Franco, et al.
Publicado: (2023)

Editorial: Measurable residual disease in hematologic malignancies
por: Buccisano, Francesco, et al.
Publicado: (2023)

Editorial: Molecular predictive pathology in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2023)

Editorial: Case reports in hematological malignancies: 2022
por: Antar, Ahmad, et al.
Publicado: (2023)

Editorial: The tumor microenvironment and malignant properties in primary liver cancer
por: Qu, Chen
Publicado: (2023)

Editorial: The Role of Platelets in Cancer Progression and Malignancy
por: Schlesinger, Martin, et al.
Publicado: (2021)

Editorial: Rising Stars in Hematologic Malignancies 2021
por: Qian, Liren, et al.
Publicado: (2022)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Editorial: Targeting redox regulation and autophagy systems for cancer therapy
por: Zhang, Junmin, et al.
Publicado: (2023)

Editorial: Developing combined modality therapy with mitochondria-targeting strategy
por: Teng, Yong
Publicado: (2023)

Photodynamic therapy for malignant brain tumors in children and young adolescents
por: Chiba, Kentaro, et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Editorial: Precision medicine approaches in radiotherapy and systemic therapy of brain metastases
por: Kaul, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ln2grq2crdqgqovqd9av1527u